Amedeo Smart

Free Medical Literature Service

 

Amedeo

Alzheimer's Disease
  Free Subscription

Articles published in
J Neurol Neurosurg Psychiatry
    April 2024
  1. KOROLOGOU-LINDEN R, Xu B, Coulthard E, Walton E, et al
    Genetics impact risk of Alzheimer's disease through mechanisms modulating structural brain morphology in late life.
    J Neurol Neurosurg Psychiatry. 2024 Apr 25:jnnp-2023-332969.
    >> Share

    March 2024
  2. ANDERSON EL, Davies NM, Korologou-Linden R, Kivimaki M, et al
    Dementia prevention: the Mendelian randomisation perspective.
    J Neurol Neurosurg Psychiatry. 2024;95:384-390.
    >> Share

    January 2024
  3. PATEL V, Edison P
    Cardiometabolic risk factors and neurodegeneration: a review of the mechanisms underlying diabetes, obesity and hypertension in Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2024 Jan 30:jnnp-2023-332661.
    >> Share

  4. KEUSS SE, Coath W, Cash DM, Barnes J, et al
    Rates of cortical thinning in Alzheimer's disease signature regions associate with vascular burden but not with beta-amyloid status in cognitively normal adults at age 70.
    J Neurol Neurosurg Psychiatry. 2024 Jan 10:jnnp-2023-332067.
    >> Share

    December 2023
  5. YANG T, Xiao Y, Cheng Y, Huang J, et al
    Epigenetic clocks in neurodegenerative diseases: a systematic review.
    J Neurol Neurosurg Psychiatry. 2023;94:1064-1070.
    >> Share

    November 2023
  6. GOLDBERG TE, Lee S, Devanand DP, Schneider LS, et al
    Comparison of relative change with effect size metrics in Alzheimer's disease clinical trials.
    J Neurol Neurosurg Psychiatry. 2023 Nov 18:jnnp-2023-331941.
    >> Share

    October 2023
  7. GRAHAM N, Zimmerman K, Heslegrave AJ, Keshavan A, et al
    Alzheimer's disease marker phospho-tau181 is not elevated in the first year after moderate-to-severe TBI.
    J Neurol Neurosurg Psychiatry. 2023 Oct 13:jnnp-2023-331854.
    >> Share

  8. LI H, Tan CC, Tan L, Xu W, et al
    Predictors of cognitive deterioration in subjective cognitive decline: evidence from longitudinal studies and implications for SCD-plus criteria.
    J Neurol Neurosurg Psychiatry. 2023;94:844-854.
    >> Share

    September 2023
  9. SHINOHARA M, Gheni G, Hitomi J, Bu G, et al
    APOE genotypes modify the obesity paradox in dementia.
    J Neurol Neurosurg Psychiatry. 2023;94:670-680.
    >> Share

  10. DUNNE R, Coulthard E
    Tipping the scales towards routine APOE genotyping.
    J Neurol Neurosurg Psychiatry. 2023;94:669.
    >> Share

    August 2023
  11. CHUN MY, Jang H, Kim SJ, Park YH, et al
    Emerging role of vascular burden in AT(N) classification in individuals with Alzheimer's and concomitant cerebrovascular burdens.
    J Neurol Neurosurg Psychiatry. 2023 Aug 9:jnnp-2023-331603.
    >> Share

    June 2023
  12. SU WM, Gu XJ, Dou M, Duan QQ, et al
    Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2023 Jun 22:jnnp-2023-331142.
    >> Share

  13. COULTHARD E, Hosseini AA
    Blood biomarkers: ready for clinical practice?
    J Neurol Neurosurg Psychiatry. 2023;94:409-410.
    >> Share

  14. LEHMANN S, Schraen-Maschke S, Vidal JS, Delaby C, et al
    Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function.
    J Neurol Neurosurg Psychiatry. 2023;94:411-419.
    >> Share

    April 2023
  15. DAI L, Gao F, Wang Q, Lv X, et al
    Molecules of senescent glial cells differentiate Alzheimer's disease from ageing.
    J Neurol Neurosurg Psychiatry. 2023 Apr 3:jnnp-2022-330743.
    >> Share

  16. ALTOMARE D, Stampacchia S, Ribaldi F, Tomczyk S, et al
    Plasma biomarkers for Alzheimer's disease: a field-test in a memory clinic.
    J Neurol Neurosurg Psychiatry. 2023 Apr 3:jnnp-2022-330619.
    >> Share

  17. VACCHIANO V, Mastrangelo A, Zenesini C, Baiardi S, et al
    Elevated plasma p-tau181 levels unrelated to Alzheimer's disease pathology in amyotrophic lateral sclerosis.
    J Neurol Neurosurg Psychiatry. 2023 Apr 3:jnnp-2022-330709.
    >> Share

  18. VAN 'T HOOFT JJ, Pelkmans W, Tomassen J, Smits C, et al
    Distinct disease mechanisms may underlie cognitive decline related to hearing loss in different age groups.
    J Neurol Neurosurg Psychiatry. 2023;94:314-320.
    >> Share

    February 2023
  19. HAZAN J, Wing M, Liu KY, Reeves S, et al
    Clinical utility of cerebrospinal fluid biomarkers in the evaluation of cognitive impairment: a systematic review and meta-analysis.
    J Neurol Neurosurg Psychiatry. 2023;94:113-120.
    >> Share

    January 2023
  20. JIANG Y, Wan M, Xiao X, Lin Z, et al
    GSN gene frameshift mutations in Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2023 Jan 17:jnnp-2022-330465.
    >> Share

    December 2022
  21. O'CONNOR A, Rice H, Barnes J, Ryan NS, et al
    First presentation with neuropsychiatric symptoms in autosomal dominant Alzheimer's disease: the Dominantly Inherited Alzheimer's Network Study.
    J Neurol Neurosurg Psychiatry. 2022 Dec 15:jnnp-2022-329843.
    >> Share

  22. HUSAIN M
    Noradrenergic therapies for apathy in Alzheimer's disease?
    J Neurol Neurosurg Psychiatry. 2022 Dec 5:jnnp-2022-330824.
    >> Share

    November 2022
  23. AYTON S, Janelidze S, Kalinowski P, Palmqvist S, et al
    CSF ferritin in the clinicopathological progression of Alzheimer's disease and associations with APOE and inflammation biomarkers.
    J Neurol Neurosurg Psychiatry. 2022 Nov 10. pii: jnnp-2022-330052.
    >> Share

    August 2022
  24. HALBGEBAUER S, Steinacker P, Hengge S, Oeckl P, et al
    CSF levels of SNAP-25 are increased early in Creutzfeldt-Jakob and Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2022 Aug 22. pii: jnnp-2021-328646.
    >> Share

  25. O'CONNOR A, Abel E, Benedet AL, Poole T, et al
    Plasma GFAP in presymptomatic and symptomatic familial Alzheimer's disease: a longitudinal cohort study.
    J Neurol Neurosurg Psychiatry. 2022 Aug 10. pii: jnnp-2022-329663.
    >> Share

  26. BARBA L, Abu Rumeileh S, Bellomo G, Paolini Paoletti F, et al
    Cerebrospinal fluid beta-synuclein as a synaptic biomarker for preclinical Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2022 Aug 9. pii: jnnp-2022-329124.
    >> Share

    July 2022
  27. DAVID MCB, Del Giovane M, Liu KY, Gostick B, et al
    Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer's disease: systematic review and meta-analysis.
    J Neurol Neurosurg Psychiatry. 2022 Jul 5. pii: jnnp-2022-329136.
    >> Share

    June 2022
  28. OVERMAN MJ, Drummond N, Butler CR, Ahmed S, et al
    Tracking the clinical progression of posterior cortical atrophy: implications for post-diagnostic and therapeutic interventions.
    J Neurol Neurosurg Psychiatry. 2022;93:683-684.
    >> Share

  29. PARNETTI L, Paolini Paoletti F, Gaetani L
    Blood biomarkers may distinguish among dementia disorders.
    J Neurol Neurosurg Psychiatry. 2022;93:571.
    >> Share

    April 2022
  30. OECKL P, Anderl-Straub S, Von Arnim CAF, Baldeiras I, et al
    Serum GFAP differentiates Alzheimer's disease from frontotemporal dementia and predicts MCI-to-dementia conversion.
    J Neurol Neurosurg Psychiatry. 2022 Apr 27. pii: jnnp-2021-328547.
    >> Share

    March 2022
  31. CHENG L, Li W, Chen Y, Lin Y, et al
    Plasma Abeta as a biomarker for predicting Abeta-PET status in Alzheimer's diseasea systematic review with meta-analysis.
    J Neurol Neurosurg Psychiatry. 2022 Mar 3. pii: jnnp-2021-327864.
    >> Share

  32. KONCZ R, Thalamuthu A, Wen W, Catts VS, et al
    The heritability of amyloid burden in older adults: the Older Australian Twins Study.
    J Neurol Neurosurg Psychiatry. 2022;93:303-308.
    >> Share

    February 2022
  33. LAGARDE J, Olivieri P, Tonietto M, Tissot C, et al
    Tau-PET imaging predicts cognitive decline and brain atrophy progression in early Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2022 Feb 28. pii: jnnp-2021-328623.
    >> Share

    January 2022
  34. CHOULIARAS L, Thomas A, Malpetti M, Donaghy P, et al
    Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsy.
    J Neurol Neurosurg Psychiatry. 2022 Jan 25. pii: jnnp-2021-327788.
    >> Share

  35. HALBGEBAUER S, Steinacker P, Verde F, Weishaupt J, et al
    Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS.
    J Neurol Neurosurg Psychiatry. 2022;93:68-74.
    >> Share

    November 2021
  36. ZHOU D, Li A, Li X, Zhuang W, et al
    Effects of 40 Hz transcranial alternating current stimulation (tACS) on cognitive functions of patients with Alzheimer's disease: a randomised, double-blind, sham-controlled clinical trial.
    J Neurol Neurosurg Psychiatry. 2021 Nov 11. pii: jnnp-2021-326885.
    >> Share

  37. ALCOLEA D, Delaby C, Munoz L, Torres S, et al
    Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias.
    J Neurol Neurosurg Psychiatry. 2021;92:1206-1214.
    >> Share

    September 2021
  38. CHONG JR, Ashton NJ, Karikari TK, Tanaka T, et al
    Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer's disease: a focused review on recent advances.
    J Neurol Neurosurg Psychiatry. 2021 Sep 11. pii: jnnp-2021-327370.
    >> Share

    June 2021
  39. RAUCHMANN BS, Schneider-Axmann T, Perneczky R
    Associations of longitudinal plasma p-tau181 and NfL with tau-PET, Abeta-PET and cognition.
    J Neurol Neurosurg Psychiatry. 2021 Jun 29. pii: jnnp-2020-325537.
    >> Share

  40. CHEUNG CY, Mok V, Foster PJ, Trucco E, et al
    Retinal imaging in Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2021 Jun 9. pii: jnnp-2020-325347.
    >> Share

    April 2021
  41. SINGLETON E, Hansson O, Pijnenburg YAL, La Joie R, et al
    Heterogeneous distribution of tau pathology in the behavioural variant of Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2021 Apr 13. pii: jnnp-2020-325497.
    >> Share

    February 2021
  42. OLIVEIRA FPM, Walker Z, Walker RWH, Attems J, et al
    (123)I-FP-CIT SPECT in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease: a new quantitative analysis of autopsy confirmed cases.
    J Neurol Neurosurg Psychiatry. 2021 Feb 4. pii: jnnp-2020-324606.
    >> Share

    December 2020
  43. HALBGEBAUER S, Oeckl P, Steinacker P, Yilmazer-Hanke D, et al
    Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2020 Dec 30. pii: jnnp-2020-324306.
    >> Share

  44. FULLGRABE C
    When hearing loss masquerades as cognitive decline.
    J Neurol Neurosurg Psychiatry. 2020;91:1248.
    >> Share

    November 2020
  45. KEIR LHM, Breen DP
    REM sleep behaviour disorder in patients without synucleinopathy.
    J Neurol Neurosurg Psychiatry. 2020;91:1239-1240.
    >> Share

    October 2020
  46. CHU CS, Li CT, Brunoni AR, Yang FC, et al
    Cognitive effects and acceptability of non-invasive brain stimulation on Alzheimer's disease and mild cognitive impairment: a component network meta-analysis.
    J Neurol Neurosurg Psychiatry. 2020 Oct 28. pii: jnnp-2020-323870.
    >> Share

  47. LU L, Zheng X, Wang S, Tang C, et al
    Anti-Abeta agents for mild to moderate Alzheimer's disease: systematic review and meta-analysis.
    J Neurol Neurosurg Psychiatry. 2020 Oct 12. pii: jnnp-2020-323497.
    >> Share

  48. KOH W, Lim L, Low A, Wong B, et al
    Development and validation of a brief visual based cognitive screening tool for dementia: the Visual Cognitive Assessment Test short-form (VCAT-S).
    J Neurol Neurosurg Psychiatry. 2020;91:1122-1123.
    >> Share

    September 2020
  49. AGIN A, Blanc F, Bousiges O, Villette C, et al
    Environmental exposure to phthalates and dementia with Lewy bodies: contribution of metabolomics.
    J Neurol Neurosurg Psychiatry. 2020;91:968-974.
    >> Share

  50. BENUSSI A, Karikari TK, Ashton N, Gazzina S, et al
    Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration.
    J Neurol Neurosurg Psychiatry. 2020;91:960-967.
    >> Share

    May 2020
  51. CHEN S, Honda T, Ohara T, Hata J, et al
    Serum homocysteine and risk of dementia in Japan.
    J Neurol Neurosurg Psychiatry. 2020;91:540-546.
    >> Share

  52. SENOVA S, Fomenko A, Gondard E, Lozano AM, et al
    Anatomy and function of the fornix in the context of its potential as a therapeutic target.
    J Neurol Neurosurg Psychiatry. 2020;91:547-559.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016